ElShatby University Maternal Hospital
Alexandria, Egypt
NCT Number: NCT06560515
This randomized controlled study was carried out on 370 pregnant women with gestational age ≥ 40 weeks of different ages and parities at El-Shatby Maternity University Hospital after approval of ethical committee of Alexandria Faculty of Medicine. After assessment for eligibility & enrollment in the study, women were randomly assigned into one of the two study groups, Group (I) received 3 mg vaginal Dinoprostone of maximum 2 doses 6 hours apart and Group (II) received 50 μg of vaginal misoprostol of maximum 2 doses 6 hours apart.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Alexandria, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
induction of labour in women with postdate pregnancy with vaginal dinoprostone vs. vaginal misoprostol
Time frame: number of women who delivered vaginally after induction
percentage of women with a successful vaginal delivery
Time frame: time from start of induction till delivery of the fetus
time lapse from receiving first dose of induction till delivery of the fetus
Time frame: after delivery of the placenta
quantification of amount of postpartum bleeding
Time frame: at 1 and 5 minutes of delivery
Apgar Score at 1 and 5 minutes
University of Alexandria
Other
Vaginal Dinoprostone Versus Vaginal Misoprostol for Induction of Labour in Post-dated Pregnancy; a Randomized Controlled Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05404776
Induced Vaginal Delivery
Galveston, Texas, United States
View Trial DetailsNCT06550232
Induced Vaginal Delivery
Nahariya, Israel
View Trial DetailsNCT05981469
Induced Vaginal Delivery
Liverpool, United Kingdom
View Trial DetailsNCT05097326
Induced Vaginal Delivery
Palo Alto, California, United States
View Trial Details